Cover Image

PAPERBACK
$43.50



View/Hide Left Panel

Provost, P.J., B.S.Wolanski, W.J.Miller, O.L.Ittensohn, W.J. McAleer, and M.R.Hilleman. 1975. Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326. Proc. Soc. Exp. Biol. Med. 148(2):532–539.

Provost, P.J., F.S.Banker, P.A.Giesa, W.J.McAleer, E.B.Buynak, and M.R.Hilleman. 1982. Progress toward a live, attenuated human hepatitis A vaccine. Proc. Soc. Exp. Biol. Med. 170(1):8–14.

Provost, P.J., P.A.Conti, P.A.Giesa, F.S.Banker, E.B.Buynak, W.J. McAleer, and M.R.Hilleman. 1983. Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates. Proc. Soc. Exp. Biol. Med. 172(3):357–363.

Purcell, R.H., S.M.Feinstone, J.R.Ticehurst, R.M.Daemer, and B.M. Baroudy. 1984. Hepatitis A virus. Pp. 9–22 in Viral Hepatitis and Liver Disease, G.N.Vyas, J.L.Dienstag, and J.H.Hoofnagle, eds. Orlando, Fla.: Grune and Stratton.


World Health Organization. 1981. World Health Organization Annual Statistical Reports, Vol. 1 and 2. Geneva: World Health Organization.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement